临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
17期
25-26,30
,共3页
张奕标%何丽丽%黄彩珍%罗南玲%范鸿%龚晓芳
張奕標%何麗麗%黃綵珍%囉南玲%範鴻%龔曉芳
장혁표%하려려%황채진%라남령%범홍%공효방
社区%熥络宝%慢性盆腔炎
社區%熥絡寶%慢性盆腔炎
사구%통락보%만성분강염
Community%Tongluobao%Chronic pelvic inflammatory diseases
目的:观察熥络宝治疗慢性盆腔炎的治疗效果。方法选择深圳市南山人民医院高新社区健康服务中心的慢性盆腔炎(伴随盆腔疼痛)患者77例,随机分组治疗组38例与对照组39例,治疗组予妇科千金胶囊口服,2粒/次,3次/d,连用14d,同时予妇康型熥络宝贴下腹,每次30min,2次/d,连用14d;对照组仅予妇科千金胶囊口服,2粒/次,3次/d,连用14d。随访3个月,对其治疗效果进行统计分析。结果治疗组30d后治愈率为73.7%,明显高于对照组的56.4%,2组比较差异有统计学意义( P<0.05);治疗组90d后治愈率为39.5%,高于对照组的15.4%,治疗组复发率为46.4%,低于对照组的72.7%,2组比较差异有统计学意义( P<0.05)。结论妇康型熥络宝辅助治疗慢性盆腔炎能显著改善治疗效果,值得临床推广应用。
目的:觀察熥絡寶治療慢性盆腔炎的治療效果。方法選擇深圳市南山人民醫院高新社區健康服務中心的慢性盆腔炎(伴隨盆腔疼痛)患者77例,隨機分組治療組38例與對照組39例,治療組予婦科韆金膠囊口服,2粒/次,3次/d,連用14d,同時予婦康型熥絡寶貼下腹,每次30min,2次/d,連用14d;對照組僅予婦科韆金膠囊口服,2粒/次,3次/d,連用14d。隨訪3箇月,對其治療效果進行統計分析。結果治療組30d後治愈率為73.7%,明顯高于對照組的56.4%,2組比較差異有統計學意義( P<0.05);治療組90d後治愈率為39.5%,高于對照組的15.4%,治療組複髮率為46.4%,低于對照組的72.7%,2組比較差異有統計學意義( P<0.05)。結論婦康型熥絡寶輔助治療慢性盆腔炎能顯著改善治療效果,值得臨床推廣應用。
목적:관찰통락보치료만성분강염적치료효과。방법선택심수시남산인민의원고신사구건강복무중심적만성분강염(반수분강동통)환자77례,수궤분조치료조38례여대조조39례,치료조여부과천금효낭구복,2립/차,3차/d,련용14d,동시여부강형통락보첩하복,매차30min,2차/d,련용14d;대조조부여부과천금효낭구복,2립/차,3차/d,련용14d。수방3개월,대기치료효과진행통계분석。결과치료조30d후치유솔위73.7%,명현고우대조조적56.4%,2조비교차이유통계학의의( P<0.05);치료조90d후치유솔위39.5%,고우대조조적15.4%,치료조복발솔위46.4%,저우대조조적72.7%,2조비교차이유통계학의의( P<0.05)。결론부강형통락보보조치료만성분강염능현저개선치료효과,치득림상추엄응용。
Objective To investigate the effect of Tongluobao in treating the chronic pelvic inflammatory diseases. Methods 77 cases of patients with chronic pelvic inflammatory disease( accompanied by pelvic pain)from the high-tech community health center of Shenzhen Nanshan People's Hospital were selected. Then they were randomly divided into treatment group(38 cases)and control group(39 cases). The treatment group was given Fuke Qianjin capsule(2 capsules,tid,14days) and Tongluobao posted in hypogastrium(0. 5h,bid,14 days);The control group was given Fuke Qianjin capsule(2 capsules, tid,14days)lonely. Followed up for 3 months,the treatment effect was analyzed statistically. Results After 30 days,the cure rate of treatment group was 73. 7%,which was higher than 56. 4% of the control group,the difference was statistically signifi-cant(P<0. 05). After 90 days,the cure rate of treatment group was 39. 5%,which was higher than 15. 4% of the control group;the recurrence rate of treatment group was 46. 4%,which was lower than 72. 7% of the control group,the differences were statistically significant(P<0. 05). Conclusion Tongluobao can significantly improve the effect in the treatment of chro-nic pelvic inflammatory diseases in community,which is worthy of clinical application.